Huntington's disease (HD) is caused by an expansion of polyglutamine tract in N-terminus of huntingtin (htt). The mutation of htt leads to dysfunction and premature death of striatal and cortical neurons. However, the effects of htt mutation on glia remain largely unknown. This study aimed to establish a glia HD model using an adenoviral vector to express wild-type and mutant N-terminal huntingtin fragment 1-552 amino acids (htt552) in rat primary cortical astrocytes. We have evaluated optimal conditions for the infection of astrocytes with adenoviral vectors, and the kinetics of the expression of htt552 in astrocytes. The majority of astrocytes expressed the transgene after infection. At 24 h postinfection, the highest rate of infection was 89 + + + + + 3% for the wild-type (htt552-18Q) with a multiplicity of infection (m.o.i.) of 80, and the highest rate of infection was 91 + + + + + 4% for the mutant type (htt552-100Q) with the same viral dose. The duration of expression of htt552 lasted for about 7 days with a relatively high level from 1 to 4 days post-infection. Mutant huntingtin (htt552-100Q) produced the characteristic HD pathology after 3 days by the appearance of cytoplasmic aggregates and intranuclear inclusions. The result of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) assay showed that the inhibition of viability by virus on astrocytes was also dose-dependent. To obtain high infection rate and low toxicity, the viral dose with an m.o.i. of 40 was optimal to our cell model. The present study demonstrates that adenoviral-mediated expression of mutant htt provides an advantageous system for histological and biochemical analysis of HD pathogenesis in primary cortical astrocyte cultures.
Introduction
Huntington's disease (HD) is a progressive, fatal, and autosomal dominant neurodegenerative disorder characterized by uncontrolled movements, cognitive deficits, and psychiatric disturbances. The mutation leading to HD has been identified as an abnormal glutamine expansion in the N-terminal portion of huntingtin (htt) in 1993 [1] . In the brain, htt is expressed in both neurons and glial cells [2, 3] . Although the striatum is the main site of degeneration in HD patients, neuronal loss may also occur in the cortex, thalamus, and other structures [4] . On the other hand, in HD patients, proliferation and activation of astrocytes were prominent, but its role in neuronal dysfunction and death remains to be studied [5, 6] . Up to date, intensive research efforts have been devoted to investigate the role of htt in neurons, however, there are few studies focusing on the effects of mutant htt on glia functions.
Development of various HD animal models has offered alternative approaches to the study of molecular pathology of this disease. Many HD models including chemically induced models and genetic models can mimic some aspects of HD symptoms and pathology [7] . In vivo studies conducted with animal models have revealed much pathogenesis of this disease. However, the complexity of in vivo tissue hampers the definition of very early pathological changes and does not allow discrimination between cell-autonomous changes and those resulted from intercellular activity processes.
Primary neuron or glial cell culture is a powerful tool for isolating cellular mechanisms, and widely used in vitro models for neurophysiological and neuropharmacological applications at present. With primary neuronal or glial culture, the environment can be defined precisely, and neurons or glial cells can be studied in isolation from other types of cells. Up to now, several primary cultured neuronal cell models of HD are available, in which primary neurons and astrocytes from HD transgenic mice and transfected neuronal and glial cultures with virus vectors are included [8 -12] . These in vitro systems have specific advantages and limitations. Primary striatal cultures obtained from transgenic mice expressing mutant htt display subtle changes in intracellular signaling pathways, but not cell death [8, 13, 14] . In contrast, neuronal degeneration and cell death have been detected in striatal cultures transfected with mutant htt fragments, but transfection efficiency was too low to allow extensive biochemical analysis [11] . In order to study the essential features of neuropathology more completely, new HD cell models, including glial cell models are needed. In this study, we developed an in vitro model of HD by infecting new-born rat cortical astrocytes with adenoviral vectors encoding the first 552 amino acids of mutant (100Q) htt. The goal of this study was to assess the infection efficiency and the kinetic process of htt552-expressing adenoviral vectors in primary rat cortical astrocytes.
Materials and Methods
Preparation of primary rat cortical astrocyte cultures Primary astrocyte cultures of rat cortex were prepared as described by McCarthy and deVellis [15] . Glial cultures were prepared from 1 to 2 days postnatal SpragueDawley rats. Dissections were performed under a stereomicroscopy in ice-cooled phosphate-buffered saline (PBS). Cerebral cortices were isolated, cut into pieces using forceps, and collected in a 15 ml Falcon centrifuge tube. The medium and buffer were removed by decanting on ice. The tissue was dissociated with 0.25% (v/v) trypsin (Sigma, St Louis, MO, USA) digestion and trituration with a fire-polished Pasteur pipette in Dulbecco's Modified Eagle Media: Nutrient Mixture F-12 (DMEM/ F12) (Gibco, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS, Hangzhou Sijiqing Biological Company, Hangzhou, China). After passing through a 40-mm-pore nylon mesh, cells were centrifuged at 48C for 5 min at 1000 g and resuspended in 10 ml of DMEM/ F12 containing 20% FBS, 100 IU/ml penicillin, and 100 mg/ml streptomycin. After plating in 25-cm 2 flasks for 30 min, cells in the supernatant were plated at a density of 1 Â 10 5 cells/cm 2 in flask coated with 0.01% poly-L-lysine (Sigma). The cultures were incubated in a humidified atmosphere of 5% CO 2 at 378C, and medium was changed twice a week. Cultures were incubated for up to 10 -12 days. After they reached confluence, these cells were isolated by standard shaking, then trypsinized, and plated in 25-cm 2 culture flasks until the cells reached confluence again. After three repetitions of this process, a pure preparation of astrocytes was obtained. The purity of cultured astrocytes was determined by immunofluorescence using the astrocytic marker anti-glial fibrillary protein (GFAP).
Adenoviral vector construction and infection
The N-terminal of wild-type (18Q) or mutant (100Q) htt of 3-kb cDNAs, with a stop codon after 552 amino acids was cloned into pDC316 adenovirus shuttle plasmid. Wild-type and mutant htt cDNAs were cleaved from their parental vectors using BamHI and XbaI and then ligated to BamHI/XbaI-digested pUC18, an intermediate vector. Then these cDNAs were ligated to BglII/SalIdigested pDC316. Two independent adenovirus shuttle plasmids, pDC316-Htt-18Q-552stop and pDC316-Htt-100Q-552stop, were obtained.
Three independent adenoviruses, Ad-null, Ad-Htt-18Q-552stop, and Ad-Htt-100Q-552stop, were obtained through cotransfecting 293A (human embryonic kidney cell line) cells with the backbone plasmid pBHG10, pDC316-Htt-18Q-552stop, and pDC316-Htt-100Q-552stop. Cytopathic effects happened at the 7th day, and the cells were collected at the 10th day. After proceeded by freeze/thaw (2208C/ 378C) for three times, the first generation adenoviruses were obtained in the cell lysates. The viruses were named Ad-htt-18Q-552aa and Ad-htt-100Q-552aa, respectively. These adenoviruses were proliferated in 293A cells to obtain the next generation according to the same method described above. Accordingly, the fourth generation adenovirus was used in the subsequent experiments. The titers were 5 Â 10 9 and 7 Â 10 9 , respectively. The prepared rat embryonic cortical astrocytes were seeded onto new flasks or plates for virus infection. At 80% confluence, cells were incubated in 2 ml DMEM/ F12 medium with 5% FBS containing adenoviral vectors with indicated dose. The virus-containing medium was removed 5 h later and replaced with fresh DMEM/F12 medium containing 20% FBS. Cell cultures infected with adenoviral vectors were incubated for the indicated time in a humidified incubator (5% CO 2 , 95% air at 378C), and the medium was changed twice a week.
above. After infection with indicated time, cell cultures were washed with cold PBS and fixed in a freshly prepared 4% paraformaldehyde (Fluka, Buchs, Schweiz) solution in PBS for 15 min at room temperature. Cells were subsequently washed with PBS and then incubated in PBS containing 0.1% Triton X-100 (Sigma) for 10 min. After being washed with PBS again, the cells were then incubated for 1 h in a blocking solution of PBS containing 2% non-fat milk (Bright dairy and Food, Shanghai, China) at room temperature. Cells were then incubated overnight at 48C in blocking solution containing mouse anti-htt monoclonal antibody 2166 (Chemicon, Temecula, CA, USA) with a dilution of 1:2000 and rabbit polyclonal anti-GFAP (Chemicon) with a dilution of 1:1000. Cells were then incubated in a blocking solution containing Cy3-conjugated donkey anti-mouse immunoglobulin G antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) with a dilution of 1:600 and fluorescein-isothiocyanateconjugated donkey anti-rabbit immunoglobulin G antibody with a dilution of 1:800 for 2 h at room temperature. After rinsing with PBS, nuclei were stained with 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; Sigma) for 10 min at room temperature. Finally, immunostained cells were rinsed with PBS and examined with a fluorescence microscope (Eclipse TE 2000-U; Nikon, Tokyo, Japan) equipped with a filter system or a confocal microscope (C1 plus sci; Nikon). Microslips were randomly scanned with confocal microscope, and six microslips were used for each group. To eliminate bias, the examiner was unaware of the experimental condition of each sample.
Protein preparation and western blot analysis
Astrocytes were harvested and rinsed with ice-cooled PBS twice. Five volumes of western blot lysing buffer (containing 20 mM Tris -HCl, pH 7.0, 20 mM ethylene diamine tetraacetic acid, 0.5% Triton X-100 supplemented with a cocktail of protease inhibitors containing 1 mM pefablock, 1 mg/ml aprotinin, and 1 mg/ml leupeptin) was added to each volume of cell pellets and incubated for 30 min on ice. After sonication on ice (1 s/ ml per sonicate, an interval of 30 s, a total of five times), the sample was centrifuged at 12,000 g at 48C for 10 min and the supernatant was collected and preserved at 2708C for later use. Protein concentrations were determined using the BCA protein assay kit (Pierce, Rockford, IL, USA) and adjusted to equal concentrations across different samples. For western blot analysis, proteins were denatured for 5 min by boiling in a loading buffer (10% sucrose, 1.2% SDS, 5% b-mercaptoethanol, and 0.025% bromophenol blue). Protein extracts were then subjected to sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis on 10% acrylamide gels and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). Membranes were blocked with 5% non-fat milk in 50 mM Tris -HCl ( pH 7.5), 150 mM NaCl, and 0.1% Tween-20, and immunoblotted with anti-htt monoclonal antibody 2166 (1:2000 dilution; Chemicon) at 48C overnight. Excessive primary antibody was removed by three washes with 0.1% Tween-20. After incubation in blocking solution containing a secondary horseradish peroxidase-conjugated antimouse antibody (Jackson ImmunoResearch Laboratories) with a dilution of 1:5000 for 1 h at room temperature, immunoreactivity was detected by enhanced chemiluminescence using the ECL kit (Amersham Pharmacia Biotech, Buckinghamshire, UK) according to the manufacturer's instructions and then visualized by autoradiography. b-actin (1:5000 dilution; Sigma) was used as a loading control and detected with a mouse monoclonal antibody (Sigma). Calculations were performed using Sigma Plot 4.11 and Prism (version 4) software.
Quantitative analysis of the cell viability of astrocytes after viral infection Astrocytes were incubated in 2 ml DMEM/F12 medium with 5% FBS containing adenoviral vectors at a multiplicity of infection (m.o.i.) of 10, 50, and 100, respectively. The virus-containing medium was removed 5 h later and replaced with fresh medium. Cell viability was determined by MTT assay 3 days after infection as described before [16] . Briefly, MTT (Sigma) solution was added to the culture medium (final concentration ¼ 500 mg/ml) 4 h before the end of treatment. The reaction was stopped by the addition of 10% acidified SDS (100 ml) to the cell culture. The absorbance value (A) was measured at 570 nm using an automatic multi-well spectrophotometer (Bio-Rad, Richmond, CA, USA). The percentage of cell viability was calculated with the following formula: inhibition rate (%) ¼ (1 2 A of experiment well/A of control well) Â 100%.
Statistical analysis
All data were presented as mean + SD. Statistical analysis was carried out using analysis of variance followed by a Student's t-test with P , 0.05 representing significance.
Results
High-efficiency expression of Ad-htt-18/100Q-552aa was achieved in primary cultured astrocytes Cerebral cortical astrocytes from new-born rats were isolated and cultured for about 14 days in DMEM/F12 medium with 20% FBS. The phenotype of the cultured cells was analyzed using the astrocytic marker GFAP. Immunofluorescence showed that about 92 + 3% of the cells in culture at 2 weeks were GFAP-positive (red), with only a few other cells [ Fig. 1(A) ].
To model HD in vitro, we infected astrocytes with an adenoviral vector encoding htt552-100Q (Ad-htt-100Q-552aa). Non-infected cultures or cultures infected with adenoviral vector encoding htt552-18Q (Ad-htt-18Q-552aa) were used as controls. Expression of htt was detected using the 2166 antibody, which recognizes the N-terminal part of human htt 552-18/100Q. Fig. 1(B) showed htt552-18Q/100Q expressions with 2166 positive labeling (green) 24 h after infection at an m.o.i. of 40.
The transgene was expressed successfully in most astrocytes. We also analyzed the expressions of human htt552-18/100Q by immunoblotting using the 2166 antibody. The result of western blot analysis also showed that htt552 transgene was expressed successfully in astrocytes at 24 h post-infection [ Fig. 1(C) ].
Mutant htt fragment (htt552-100Q) accumulated in astrocytes and formed cytoplasmic aggregates and nuclear inclusions The presence of cytoplasmic aggregates and nuclear inclusions in neurons is a typical pathological feature of HD [17] [18] [19] . We monitored the appearance of htt aggregates in astrocytes 3 days after infection with Ad-htt-18/ 100Q-552aa. As expected, htt552-18Q distributed in the cytoplasm of infected astrocytes diffusely with a few small patches in the cytoplasm. However, htt552-100Q formed significantly larger and more abundant aggregates in both the cytoplasm and nucleus (Fig. 2) . Moreover, mutant htt552-100Q forms cytoplasmic aggregates which were Fig. 3(B) ]. These results indicated that the percentage of astrocytes expressing htt552-18/100Q is a function of the viral dose. However, after infected with Ad-htt-18/100Q-552aa at an m.o.i. of 80, this increase in infection efficiency was not significant when compared with that at an m.o.i. of 40 [ Fig. 3(A and B) ]. The western blot analysis revealed that the protein levels of htt552-18/100Q at an m.o.i. of 50 and 100 were both significantly higher than those at an m.o.i. of 10 (P , 0.01), but there was no significant difference between an m.o.i. of 50 and 100 (Fig. 4) . The result of western blot was consistent with the trend of immunofluorescence results showed above.
The level of expressed htt552 was a function of the time of culture Rat cerebral cortical astrocytes were infected with Ad-htt-18Q-552aa or Ad-htt-100Q-552aa at an m.o.i of 40, and then collected 0.5, 1, 4, and 7 days after infection for analysis. Immunofluorescence showed that htt552 expression with 2166 positive labeling can be observed from 0.5 days after infection, and lasted for 7 days. At 1 day post-infection, the percentage of htt552-expressing astrocytes (18Q: 76 + 6%; 100Q: 83 + 5%) was significantly higher than that at 0.5 days (18Q: 48 + 6%; 100Q: 39 + 2%). At 4 days post-infection, the percentage of htt552-18Q-expressing astrocytes (68 + 4%) was lower than the percentage at 1 day, but no significant difference was found between them. At 7 days post-infection, the percentage of htt552-18Q-expressing astrocytes (27 + 5%) was significantly lower than that at 1 day (P , 0.01). The percentage of htt552-100Q expressing astrocytes had a trend similar to that of htt552-18Q. However, the percentage of htt552-100Q-expressing astrocytes (73 + 2%) at 4 days post-infection was decreased significantly than that at 1 day (P , 0.05). The results indicated that the percentage of astrocytes expressing htt552-18/100Q is a function of the time of culture [ Fig. 5(A) ]. The data from immunoblotting further support our conclusion [ Fig. 5(B) ]. The western blot analysis revealed that the transgenes of Ad-htt552 were expressed in astrocytes from 1 to 7 days post-infection. The protein levels of htt552 at 4 days decreased when compared with that at 1 day post-infection, but only those expressing htt552-100Q reached statistically significant level (P , 0.05). The protein levels of htt552-18/100Q at 7 days were significantly lower when compared with those at 1 day post-infection [P , 0.01; Fig. 5(B) ].
Cytotoxicity of adenoviral vectors expressing htt552 on astrocytes was dose-dependent After exposed to various concentrations of viruses for 3 days, the cell cytotoxicity of virus vector was determined using the MTT assay. The result showed that the cytotoxicity of adenoviral vector was dose-dependent. After infection with Ad-null, Ad-htt-552-18Q, or Ad-htt552-100Q, the inhibition rate on cell viability increased with virus dose. Adenovirus vectors induce cellular inflammatory response that is triggered by a lowlevel of viral protein expression and antigenic processing of viral proteins. Therefore, high dose of adenovirus can induce the cell death directly [20] . Following 3 days of infection with Ad-htt552-18Q, the MTT assay revealed that the inhibition rate on cell viability at an m.o.i. of 50 was 10 + 5%, and the inhibition rate increased to 47 + 6% when the m.o.i. was 100. There was no significant difference in the inhibition rates between Ad-htt552-18Q and Ad-null. However, at 3 days after infection with Ad-htt552-100Q, the MTT assay revealed that the inhibition rate on cell viability at an m.o.i. of 50 was 43 + 11%, and the inhibition rate increased to 60 + 5% when the m.o.i. was 100. Compared with Ad-null and Ad-htt552-18Q, the inhibition rate on viability of astrocytes expressing Ad-htt-100Q-552 at an m.o.i. of 50 or 100 was significantly higher (P , 0.01). This indicated that the expression of mutant htt552 possibly induces the degeneration and death of astrocytes, which requires further investigation (Fig. 6) .
Discussion
Glial cells constitute 90% of the cells in the brain and can be classified as astrocytes, microglias, and oligodendrocytes. Astrocytes, the most abundant glial cell type in the brain, play a crucial role in maintaining normal brain physiology during development and in adulthood. Up to date, it is confirmed that astrocytes have some important functions including formation of growth tracts during brain development, production of neurotrophic factors, conservation of glycogen, regulation of extracellular ionic composition, uptake and degradation of some neurotransmitters, formation of blood-brain barrier, angiogenesis include endothelial differentiation, immune response, formation of scar tissue after neuronal loss and neurotransmission. In addition to these physiological roles, astrocytes play an important role in responding to disease and injury. Common astrocytic reactions that occur in the pathological conditions are cellular swelling, astrogliosis, and astrocytosis. These reactive astrocytic changes are observed in viral infections, inflammatory demyelinating disease, acute traumatic brain injury, ischemia, multiple sclerosis, Down's syndrome, Alzheimer's disease, and HD [21] .
Up to now, little is known about the role of glia in HD neuropathology. Previous studies have reported that mutant htt and its aggregate is present in the astrocytes of HD patients and model animal brains [2, 22] . Shin et al. reported that mutant huntingtin accumulates in glial nuclei in HD brains and decreases the expression of glutamate transporters. As a result, mutant huntingtin reduced glutamate uptake in cultured astrocytes and HD mouse brains, and decreased their protection of neurons against glutamate excitotoxicity [12] . Szu-Yi Chou et al. revealed that primary astrocytes prepared from R6/2 mice produced less chemokine [(C-C motif ) ligand 5 (CCL5)/regulated on activation of normal T cell expressed and secreted (RANTES)] than wild-type astrocytes. They also found that mutant htt suppresses the availability of astrocytic CCL5/RANTES to neurons through two different mechanisms: reduced transcription and defective release [23] . Mutant htt may affect various functions of astrocytes, including their production of chemokines and neurotrophic factors, although these possibilities remain to be explored.
In order to study the neuropathology of HD, we developed an in vitro model of HD by infecting new-born rat cortical astrocytes with adenoviral vectors encoding the first 552 amino acids of mutant htt (htt552-100Q). In this astrocytes HD model, a high infection rate was obtained and the transgene expression was maintained at high levels from 1 to 4 days post-infection. Our model offered a new opportunity to analyze the effects of mutant htt on glial functions.
The methods that have been used to deliver a gene into neurons or astrocytes can be divided into non-viraland viral-based methods. The non-viral methods have been hampered by the problem of low transduction efficiency. In contrast, viral methods, which include the use of adenovirus, adeno-associated virus, herpes simplex virus, and retroviral vectors, display a higher transduction rate [20] . Previous studies demonstrated that the level of htt expression is an important factor in the generation of HD models. For example, studies on transgenic mice found no differences in survival rates between striatal cultures derived from wild-type and mutant (R6/2 and YAC72) littermates [8, 14] . In contrast, primary neurons transfected with a plasmid-expressing mutant htt degenerated after a few days as a result of very high transgene expression [11] .
The percentage of htt552-expressing astrocytes increased with increasing doses of adenoviral vectors. In order to increase the percentage of htt552-expressing astrocytes, high doses of adenoviral vectors were needed. However, the result of MTT assay showed that the viability of astrocytes decreased with higher viral doses. Therefore, an optimal viral dose used to obtain high infection rate and low toxicity needs to be predetermined. The present results showed that, at 24 h after infection, the percentage of htt552-18/100Q-expressing astrocytes with an m.o.i. of 40 was 81 + 5% and 83 + 7%. Meanwhile, the cytotoxicity was not a serious problem at this viral dose. It indicates that this virus dose is optimal to our cell model. High infection efficiency is the first advantage of the present model. It allows quantitative analyses of mutant htt-induced cellular changes with molecular and biochemical approaches in cortical astrocytes, an approach previously restricted to immortalized cell lines.
Huntingtin (htt) was a neuronal protein shown to be caspase substrate with defined sites for caspase-3 at amino acids 513 and 552, for caspase-2 at amino acid 552, and for caspase-6 at amino acid 586. In addition, there are two caspase-3 consensus sites at amino acids 530 and 589 that appear to be silent [24] [25] [26] . Our previous study demonstrated that htt can also be cleaved by thrombin in vitro [27] . However, in vivo, amino acid 552 was defined as a preferred site of caspase cleavage in human HD, in YAC72 transgenic mice, and in control human and murine brain [28] . Up to date, its normal function for wild-type htt552 and pathological roles of mutant htt552 are still unknown. Therefore, in the present model, the transgene of htt552, not other fragments which does not exist in HD brain naturally, was used to be the subject of study.
HD is a protein misfolding disease. The bio-hallmark of HD is the formation of intranuclear inclusions and cytoplasmic aggregates in neurons in vulnerable brain areas. The inclusions and aggregates are usually formed by small N-terminal htt fragments and are co-localized with other cellular proteins involved in proteolysis, vesicle trafficking, and protein degradation [17] [18] [19] . Our previous study demonstrated that the polyglutamine domain, but not the polyproline domain, plays a role in the sequestration of GAPDH to aggregates by mutant htt. This effect might contribute to the dysfunction of neurons caused by mutant htt in HD [29] . In the present model, cytoplasmic aggregates and nuclear inclusions formed from htt552-100Q appeared three days after infection. The presence of aggregates in both compartments probably interferes in various intracellular pathways that led ultimately to the degeneration of primary astrocytes.
The aggregates formed by 100Q fragment were not detected with western blot analysis, due to small percentage of htt-expressing cells had htt aggregates. In our model, the number of aggregates was 15 + 3% in the htt552-100Q-infected astrocytes at 3 days post-infection. As more than 80% of the astrocytes expressed htt552-100Q, these data suggested that most infected astrocytes do not develop aggregates. This might be due to the short expressing time of transgene with adenoviral vectors. This result was consistent with the previous study. Shin et al. found that the prevalence of nuclear htt aggregates in glial cells was increased with aging in R6/2 mice. In the striatum, 17.6% of glial cells showed intranuclear htt staining at 4-5 weeks, whereas 42% and 52.6% of glial cells displayed nuclear htt at 8-9 and 11-12 weeks. In white matter, a similar age-dependent increase of intranuclear htt was also seen. Moreover, the accumulation of mutant htt in glial nuclei occurs noticeably later than that in neurons, suggesting that glial cells are more capable of clearing misfolded htt than neuronal cells [12] . Diana Zala et al. developed an in vitro model of HD by infecting E16 rat striatal neurons with a lentiviral vector encoding the first 171 amino acids of mutant (82Q) htt. In this model, they found that no nuclear inclusions were present in the htt171-82Q-infected cultures up to 2 weeks post-infection. At 4 weeks, 31 + 3% of neurons had at least one ubiquitinated nuclear inclusion. After 6 weeks, the proportion of ubiquitinpositive inclusions reached 56 + 3%. However, this percentage declined to 46 + 2% between 6 and 8 weeks, possibly as a result of neuronal death [30] . Therefore, aggregates and inclusions in neurons and glial cells were developed progressively and slowly in the brain of HD patients. Our glial cell model could not reflect this progressive pathological change because of the short expressing time of adenoviral vectors.
Our acute HD cell model offered a useful tool to analyze the effects of mutant htt on glia functions. First, this model can be used to study the differences in htt cleavage and accumulation in astrocytes and neurons. Secondly, the present model can be used to observe the influence of mutant htt on astrocyte functions. Using a similar model, Ji-Yeon Shin et al. [12] have found that mutant htt decreases the expression of glutamine transporters in glial cell membrane. We will further study the effects of mutant htt on production of cytokines and neurotrophic factors using current cell model. In summary, we developed an in vitro model of HD by infecting new-born rat cortical astrocytes with adenoviral vectors encoding the first 552 amino acids of mutant (100Q) htt. The optimal condition for infecting cortical astrocytes was incubating with astrocytes for 5 h with a viral dose at an m.o.i. of 40. The high infection rate was obtained from 1 to 4 days after infection. This cellular model would be particularly useful for further dissecting HD pathology, screening therapeutic candidates, and analyzing the intracellular mechanisms associated with the neuroprotective effects of various agents. 
